Literature DB >> 9605863

Genomic cloning and localization of CTAG, a gene encoding an autoimmunogenic cancer-testis antigen NY-ESO-1, to human chromosome Xq28.

Y T Chen1, A D Boyer, C S Viars, S Tsang, L J Old, K C Arden.   

Abstract

CTAG was initially cloned from an esophageal squamous cell carcinoma cDNA expression library by immunoscreening with autologous patient's serum. CTAG mRNA is expressed in a proportion of human cancers in a lineage-nonspecific fashion, whereas its expression in normal tissues is restricted to testis and ovary only. This expression pattern suggests that the CTAG product (NY-ESO-1) is an aberrantly activated tumor antigen and can potentially be an antigenic target for tumor vaccination. In the present study, we isolated human genomic clones of CTAG and established its genomic organization. By somatic cell hybrid studies and fluorescence in-situ hybridization, we localized this gene to chromosome Xq28, a region that also contains members of MAGE, a gene family that encodes several immunogenic tumor antigens with the characteristic cancer/testis expression pattern.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9605863     DOI: 10.1159/000134734

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  27 in total

Review 1.  Biological significance of HORMA domain containing protein 1 (HORMAD1) in epithelial ovarian carcinoma.

Authors:  Mian M K Shahzad; Yong-Hyun Shin; Koji Matsuo; Chunhua Lu; Masato Nishimura; De-Yo Shen; Yu Kang; Wei Hu; Edna M Mora; Cristian Rodriguez-Aguayo; Arvinder Kapur; Justin Bottsford-Miller; Gabriel Lopez-Berestein; Aleksandar Rajkovic; Anil K Sood
Journal:  Cancer Lett       Date:  2012-07-07       Impact factor: 8.679

Review 2.  Cancer/testis (CT) antigens, carcinogenesis and spermatogenesis.

Authors:  Yan-Ho Cheng; Elissa Wp Wong; C Yan Cheng
Journal:  Spermatogenesis       Date:  2011-07-01

3.  Establishment and characterization of a new human myxoid liposarcoma cell line (DL-221) with the FUS-DDIT3 translocation.

Authors:  Marieke A de Graaff; Jamie S E Yu; Hannah C Beird; Davis R Ingram; Theresa Nguyen; Jeffrey Juehui Liu; Svetlana Bolshakov; Károly Szuhai; Pierre Åman; Keila E Torres; Dina Lev; Torsten O Nielsen; Judith V M G Bovée; Alexander J Lazar; Neeta Somaiah
Journal:  Lab Invest       Date:  2016-06-06       Impact factor: 5.662

Review 4.  Identifying and Targeting Human Tumor Antigens for T Cell-Based Immunotherapy of Solid Tumors.

Authors:  Vid Leko; Steven A Rosenberg
Journal:  Cancer Cell       Date:  2020-08-20       Impact factor: 31.743

Review 5.  LDH-C4: a target with therapeutic potential for cancer and contraception.

Authors:  G S Gupta
Journal:  Mol Cell Biochem       Date:  2012-08-15       Impact factor: 3.396

6.  Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.

Authors:  E Jäger; Y Nagata; S Gnjatic; H Wada; E Stockert; J Karbach; P R Dunbar; S Y Lee; A Jungbluth; D Jäger; M Arand; G Ritter; V Cerundolo; B Dupont; Y T Chen; L J Old; A Knuth
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

7.  Expression and immunogenicity of NY-ESO-1 in colorectal cancer.

Authors:  Ya Li; Ruifeng Song; Xinqiang Li; Feng Xu
Journal:  Exp Ther Med       Date:  2017-04-28       Impact factor: 2.447

8.  The cancer/testis antigen CAGE with oncogenic potential stimulates cell proliferation by up-regulating cyclins D1 and E in an AP-1- and E2F-dependent manner.

Authors:  Elaine Por; Hee-Jung Byun; Eun-Ju Lee; Jeong-Hee Lim; So-Young Jung; Iha Park; Young-Myeong Kim; Doo-Il Jeoung; HanSoo Lee
Journal:  J Biol Chem       Date:  2010-03-10       Impact factor: 5.157

9.  Rapid generation of NY-ESO-1-specific CD4+ THELPER1 cells for adoptive T-cell therapy.

Authors:  Simone Kayser; Cristina Boβ; Judith Feucht; Kai-Erik Witte; Alexander Scheu; Hans-Jörg Bülow; Stefanie Joachim; Stefan Stevanović; Michael Schumm; Susanne M Rittig; Peter Lang; Martin Röcken; Rupert Handgretinger; Tobias Feuchtinger
Journal:  Oncoimmunology       Date:  2015-05-21       Impact factor: 8.110

10.  Synergistic induction of NY-ESO-1 antigen expression by a novel histone deacetylase inhibitor, valproic acid, with 5-aza-2'-deoxycytidine in glioma cells.

Authors:  Sachie Oi; Atsushi Natsume; Motokazu Ito; Yutaka Kondo; Shinji Shimato; Yuka Maeda; Kiyoshi Saito; Toshihiko Wakabayashi
Journal:  J Neurooncol       Date:  2008-11-22       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.